Font: Financial Modeling Prep • Dec 02, 2025
Vestis Corporation (NYSE:VSTS) has been a topic of discussion among investors and analysts due to its recent stock performance and financial updates. On December 2, 2025, Goldman Sachs maintained a "Neutral" rating for VSTS, suggesting investors hold onto the stock. The firm adjusted its price target from $5.50 to $6.30, slightly above the stock's price at the time, which was $6.23.
The Q4 2025 earnings call for Vestis featured CEO James Barber and CFO Kelly Janzen, with participation from notable firms such as William Blair & Company and JPMorgan Chase & Co. This event provided valuable insights into the company's financial health and future plans. Despite the stock's price decrease of 7.29%, or $0.49, on the day of the call, it highlighted the market's reaction to Vestis's performance and strategic decisions.
VSTS has seen significant price fluctuations over the past year, with a daily range between $5.30 and $6.45, and a yearly high and low of $17.83 and $3.98, respectively. These movements reflect the volatility and investor sentiment towards the company. With a market capitalization of approximately $821.4 million and a trading volume of 6,210,290 shares on the NYSE, VSTS continues to be an actively traded stock, attracting attention from both investors and analysts.
|
ALP§>
AlphaTON Capital Corp. Common Stock
|
$0.37
38.41%
|
|
ATON§>
AlphaTON Capital Corp.
|
$0.35
32.40%
|
|
SNAL§>
Snail, Inc. Class A Common Stock
|
$1.36
169.87%
|
|
QUCY§>
Mainz Biomed N.V.
|
$3.19
137.69%
|
|
SOXS§>
Direxion Daily Semiconductor Bear 3X ETF
|
$8.21
-1.67%
|
|
EZGO§>
EZGO Technologies Ltd.
|
$0.03
-18.69%
|
|
ONDS§>
Ondas Holdings Inc.
|
$10.97
23.81%
|
|
F§>
Ford Motor Company
|
$14.49
6.78%
|
|
TZA§>
Direxion Daily Small Cap Bear 3X ETF
|
$4.62
-1.91%
|
|
SRXH§>
SRx Health Solutions Inc.
|
$0.14
-8.18%
|